Cargando…
Lurasidone for Treating Schizophrenia and Bipolar Depression: A Review of Its Efficacy
Lurasidone is an antipsychotic medication that blocks dopamine D2 and serotonin 5-hydroxy-tryptamine (5-HT)(2A )receptors and affects other serotoninergic and noradrenergic receptors. It has rapid absorption and linear pharmacokinetics. The rates of metabolic syndrome for patients taking lurasidone...
Autores principales: | Tarzian, Martin, Soudan, Majd, Alhajji, Muhammed, Ndrio, Mariana, Fakoya, Adegbenro O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208134/ https://www.ncbi.nlm.nih.gov/pubmed/37228542 http://dx.doi.org/10.7759/cureus.38071 |
Ejemplares similares
-
Cariprazine for Treating Schizophrenia, Mania, Bipolar Depression, and Unipolar Depression: A Review of Its Efficacy
por: Tarzian, Martin, et al.
Publicado: (2023) -
An Introduction and Brief Overview of Psychoanalysis
por: Tarzian, Martin, et al.
Publicado: (2023) -
Illuminating Hope for Mental Health: A Drug Review on Lumateperone
por: Tarzian, Martin, et al.
Publicado: (2023) -
An Assessment of the 10-Year Risk of Developing Type 2 Diabetes Among Saudi Adults Based on the Finnish Diabetes Risk Score
por: Elshebiny, Ahmed, et al.
Publicado: (2022) -
Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression
por: Loebel, Antony, et al.
Publicado: (2015)